Transcranial Magnetic Stimulators (TMS) Market

Global Transcranial Magnetic Stimulators (TMS) Market Size, Trends & Analysis - Forecasts to 2027 By Application (Tinnitus, Alzheimer, Parkinsons Disease, Psychiatric Disorders, Stroke, and Others), By Type (Single-pulse Transcranial Magnetic Stimulators and Repetitive Pulse Transcranial Magnetic Stimulators), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

Category Healthcare

Format

This report was recently updated on November 18 2024 with the latest and most recent market numbers

Global Transcranial Magnetic Stimulators (TMS) Market Size

The global transcranial magnetic stimulators (TMS) market is projected to grow at a CAGR value of 8.5% during the forecast period of 2022 to 2027.

TMS (transcranial magnetic stimulation) is a neurobiological treatment for unobtrusive nervous system stimulation. TMS is superior to electroconvulsive therapy (ECT) because it is targeted and avoids the resistance of the skull and the production of identical tissues. During the forecast period, the rising acceptability of the treatment to deal with patients who may not respond to psychoanalysis or antidepressant medication, as well as other illnesses such as Parkinson’s disease, will drive expansion. However, side-effects associated with TMS therapy, including neck pain, mild headaches, and altered cognition during treatment, as well as a rising proportion of patients embracing the therapy, are expected to stifle growth during the projection period.

One of the major factors driving market expansion is the rising prevalence of neurological diseases among the proportion of older people, as well as the quick emergence of non-invasive, electrostatic pulse-administered therapy for neurological disorders. Furthermore, rising anxiety and depression rates, particularly during the coronavirus pandemic, will contribute to the worldwide industry's growth over the forecast period. As per Our World in Data report, 3.94% percentage of the global population suffers from select mental health or substance abuse disorders as of 2019.

Researchers estimate that over 4 million people in the United States had Alzheimer's Disease (AD) in 2019, and the number of persons with dementia is anticipated to rise from 50 million to 152 million in 2050 as a result, market growth is likely to be aided by the rising prevalence of Alzheimer's disease and dementia coupled with the growing number of government approval for devices, the market for stimulators is burgeoning during the forecast period.

During the early months of the pandemic, interim suspensions of medical institutions and reduced or halted treatment options for non-COVID patients provided difficulties to the industry's expansion. However, the rising incidence of Alzheimer's disease among COVID-19-affected patients, as well as a surge in blood-based biochemical indicators for Alzheimer's disease, are driving higher demand for TMS treatments, increasing the chance of developing cancer during the pandemic.

global transcranial magnetic stimulators (tms) market

Global Transcranial Magnetic Stimulators (TMS) Market: By Application

Based on the application, the global transcranial magnetic stimulators (TMS) market is divided into tinnitus, Alzheimer's, Parkinson’s disease, psychiatric disorders, stroke, and others.

The Alzheimer’s disease segment is expected to grow the fastest in the TMS market from 2022 to 2027. TMS helps Alzheimer's patients enhance their cognitive abilities, memory, and communication, especially in the early stages of the disease. Thus, in the mild stage of Alzheimer's disease, TMS can be recommended as viable adjuvant therapy in combination with cholinesterase inhibitors. According to studies published in well-reputed journals, Alzheimer's disease is the third largest cause of mortality in high-income countries, with 82 million individuals expected to be diagnosed by 2030.

Global Transcranial Magnetic Stimulators (TMS) Market: By Type

Based on the type, the global transcranial magnetic stimulators (TMS) market is divided into single-pulse transcranial magnetic stimulators and repetitive pulse transcranial magnetic stimulators.

The repetitive pulse transcranial magnetic stimulators segment is expected to grow the fastest in the market from 2022 to 2027. As it is considered a novel therapy for anxiety and depression that allows direct stimulation of deeper and greater neuroimaging. It has been discovered that repetitive transcranial magnetic stimulation (rTMS) could be used to treat a variety of mental diseases, notably unipolar depression, schizophrenia, and bipolar disorder. As a result, doctors' recommendations and investigations on rTMS are projected to have a beneficial impact on market growth.

asia pacific transcranial magnetic stimulators (tms) market

Global Transcranial Magnetic Stimulators (TMS) Market: By Region

As per the geographical analysis, the global transcranial magnetic stimulators (TMS) Market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

North America (the United States, Canada, and Mexico) will have a dominant share in the global transcranial magnetic stimulators (TMS) market from 2022 to 2027. The major factor driving the growth of the market in this region is the rising prevalence of the aging population, favorable regulatory practices in the transcranial magnetic stimulators market, attractive reimbursement rules, and the prevalence of well-established healthcare institutions in the region.

Moreover, the Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific) region is expected to be a high CAGR in the global transcranial magnetic stimulators (TMS) Market during the forecast period. Due to the rising frequency of physiological and neurological illnesses, increased government initiatives, and the expanding number of awareness campaigns run by NGOs. The need for TMS treatment in the region will grow as the number of individuals diagnosed with migraines is rising with an increase in medical tourism and healthcare spending as supportive government schemes are being launched.

Global Transcranial Magnetic Stimulators (TMS) Market Share and Competitor Analysis

Axium Robotics, Brainbox, TeleMag Health, Brainsway, Dr. Langer Medical, eNeura, MAG & More GmbH, The Magstim Company Limited, MagVenture, Neuronetics, Neurosoft (OPAP Investment), Nexstim, Remed, Yiruide, TMS Neuro Solutions, neuroCare Group GmbH, EB Neuro, among others are the key players in the global transcranial magnetic stimulators (TMS) market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Transcranial Magnetic Stimulators (TMC) Industry Overview, 2022-2027

2.1.1 Industry Overview

2.1.2 Application Overview

2.1.3 Type Overview

2.1.4 Regional Overview

Chapter 3 Transcranial Magnetic Stimulators (TMC) Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2022-2027

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Rise in Patients Suffering from Depression and Other Neurological Diseases

3.3.2 Industry Challenges

3.3.2.1 Side-effects associated with TMS therapy, including neck pain, mild headaches, and altered cognition during treatment

3.4 Prospective Growth Scenario

3.4.1 Application Growth Scenario

3.4.2 Type Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-User Overview

3.11 Market Share Analysis, 2021

3.11.1 Company Positioning Overview, 2021

Chapter 4 Transcranial Magnetic Stimulators (TMC) Market, By Application

4.1 Application Outlook

4.2 Tinnitus

4.2.1 Market Size, By Region, 2022-2027 (USD Billion)

4.3 Alzheimer

4.3.1 Market Size, By Region, 2022-2027 (USD Billion)

4.4 Parkinson’s Disease

4.4.1 Market Size, By Region, 2022-2027 (USD Billion)

4.5 Psychiatric Disorders

4.5.1 Market Size, By Region, 2022-2027 (USD Billion)

4.6 Stroke

4.6.1 Market Size, By Region, 2022-2027 (USD Billion)

4.7 Others

4.7.1 Market Size, By Region, 2022-2027 (USD Billion)

Chapter 5 Transcranial Magnetic Stimulators (TMC) Market, By Type

5.1 Type Outlook

5.2 Single pulse transcranial magnetic stimulators

5.2.1 Market Size, By Region, 2022-2027 (USD Billion)

5.3 Repetitive pulse transcranial magnetic stimulators

5.3.1 Market Size, By Region, 2022-2027 (USD Billion)

Chapter 6 Transcranial Magnetic Stimulators (TMC) Market, By Region

6.1 Regional outlook

6.2 North America

6.2.1 Market Size, By Country 2022-2027 (USD Billion)

6.2.2 Market Size, By Application, 2022-2027 (USD Billion)

6.2.3 Market Size, By Type, 2022-2027 (USD Billion)

6.2.4 U.S.

6.2.4.1 Market Size, By Application, 2022-2027 (USD Billion)

6.2.4.2 Market Size, By Type, 2022-2027 (USD Billion)

6.2.5 Canada

6.2.5.1 Market Size, By Application, 2022-2027 (USD Billion)

6.2.5.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3 Europe

6.3.1 Market Size, By Country 2022-2027 (USD Billion)

6.3.2 Market Size, By Application, 2022-2027 (USD Billion)

6.3.3 Market Size, By Type, 2022-2027 (USD Billion)

6.3.4 Germany

6.3.4.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.4.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3.5 UK

6.3.5.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.5.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3.6 France

6.3.6.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.6.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3.7 Italy

6.3.7.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.7.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3.8 Spain

6.3.8.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.8.2 Market Size, By Type, 2022-2027 (USD Billion)

6.3.9 Russia

6.3.9.1 Market Size, By Application, 2022-2027 (USD Billion)

6.3.9.2 Market Size, By Type, 2022-2027 (USD Billion)

6.4 Asia Pacific

6.4.1 Market Size, By Country 2022-2027 (USD Billion)

6.4.2 Market Size, By Application, 2022-2027 (USD Billion)

6.4.3 Market Size, By Type, 2022-2027 (USD Billion)

6.4.4 China

6.4.4.1 Market Size, By Application, 2022-2027 (USD Billion)

6.4.4.2 Market Size, By Type, 2022-2027 (USD Billion)

6.4.5 India

6.4.5.1 Market Size, By Application, 2022-2027 (USD Billion)

6.4.5.2 Market Size, By Type, 2022-2027 (USD Billion)

6.4.6 Japan

6.4.6.1 Market Size, By Application, 2022-2027 (USD Billion)

6.4.6.2 Market Size, By Type, 2022-2027 (USD Billion)

6.4.7 Australia

6.4.7.1 Market Size, By Application, 2022-2027 (USD Billion)

6.4.7.2 Market size, By Type, 2022-2027 (USD Billion)

6.4.8 South Korea

6.4.8.1 Market Size, By Application, 2022-2027 (USD Billion)

6.4.8.2 Market Size, By Type, 2022-2027 (USD Billion)

6.5 Latin America

6.5.1 Market Size, By Country 2022-2027 (USD Billion)

6.5.2 Market Size, By Application, 2022-2027 (USD Billion)

6.5.3 Market Size, By Type, 2022-2027 (USD Billion)

6.5.4 Brazil

6.5.4.1 Market Size, By Application, 2022-2027 (USD Billion)

6.5.4.2 Market Size, By Type, 2022-2027 (USD Billion)

6.5.5 Mexico

6.5.5.1 Market Size, By Application, 2022-2027 (USD Billion)

6.5.5.2 Market Size, By Type, 2022-2027 (USD Billion)

6.5.6 Argentina

6.5.6.1 Market Size, By Application, 2022-2027 (USD Billion)

6.5.6.2 Market Size, By Type, 2022-2027 (USD Billion)

6.6 MEA

6.6.1 Market Size, By Country 2022-2027 (USD Billion)

6.6.2 Market Size, By Application, 2022-2027 (USD Billion)

6.6.3 Market Size, By Type, 2022-2027 (USD Billion)

6.6.4 Saudi Arabia

6.6.4.1 Market Size, By Application, 2022-2027 (USD Billion)

6.6.4.2 Market Size, By Type, 2022-2027 (USD Billion)

6.6.5 UAE

6.6.5.1 Market Size, By Application, 2022-2027 (USD Billion)

6.6.5.2 Market Size, By Type, 2022-2027 (USD Billion)

6.6.6 South Africa

6.6.6.1 Market Size, By Application, 2022-2027 (USD Billion)

6.6.6.2 Market Size, By Type, 2022-2027 (USD Billion)

Chapter 7 Company Landscape

7.1 Competitive Analysis, 2020

7.2 Axilum Robotics

7.2.1 Company Overview

7.2.2 Financial Analysis

7.2.3 Strategic Positioning

7.2.4 Info Graphic Analysis

7.3 Brainbox

7.3.1 Company Overview

7.3.2 Financial Analysis

7.3.3 Strategic Positioning

7.3.4 Info Graphic Analysis

7.4 TeleMag Health

7.4.1 Company Overview

7.4.2 Financial Analysis

7.4.3 Strategic Positioning

7.4.4 Info Graphic Analysis

7.5 Brainsway

7.5.1 Company Overview

7.5.2 Financial Analysis

7.5.3 Strategic Positioning

7.5.4 Info Graphic Analysis

7.6 Dr. Langer Medical

7.6.1 Company Overview

7.6.2 Financial Analysis

7.6.3 Strategic Positioning

7.6.4 Info Graphic Analysis

7.7 eNeura

7.7.1 Company Overview

7.7.2 Financial Analysis

7.7.3 Strategic Positioning

7.7.4 Info Graphic Analysis

7.8 MAG & More GmbH

7.8.1 Company Overview

7.8.2 Financial Analysis

7.8.3 Strategic Positioning

7.8.4 Info Graphic Analysis

7.9 The Magstim Company Limited

7.9.1 Company Overview

7.9.2 Financial Analysis

7.9.3 Strategic Positioning

7.9.4 Info Graphic Analysis

7.10 Other Companies

7.10.1 Company Overview

7.10.2 Financial Analysis

7.10.3 Strategic Positioning

7.10.4 Info Graphic Analysis

The Global Transcranial Magnetic Stimulators (TMS) Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Transcranial Magnetic Stimulators (TMS) Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the transcranial magnetic stimulators (TMS) market?

The global transcranial magnetic Stimulators (TMS) market is projected to grow at a CAGR value of 8.5% from 2022 to 2027.

Who are the major vendors in the transcranial magnetic stimulators (TMS) market?

Which region has the highest market share in the transcranial magnetic stimulators (TMS) market?

The North American region is estimated to dominate the market in the transcranial magnetic stimulators (TMS) market.

What is the Covid-19 impact on future transcranial magnetic stimulators (TMS) market?

During the early months of the pandemic, interim suspensions of medical institutions and reduced or halted treatment options for non-COVID patients provided difficulties to the industrys expansion. However, the rising incidence of Alzheimers disease among COVID-19-affected patients, as well as a surge in blood-based biochemical indicators for Alzheimers disease, are driving higher demand for TMS treatments, increasing the chance of developing cancer during the pandemic.

What are the major drivers in the acoustic metamaterials market?

During the forecast period, the rising acceptability of the treatment to deal with patients who may not respond to psychoanalysis or antidepressant medication, as well as other illnesses such as Parkinsons disease, will drive expansion.